Answers are grounded in this paper and cite their sources.
Case report shows successful home intravenous heparin therapy for recurrent strokes in a patient with cancer, indicating potential for improved outcomes.
Cancer-associated stroke (CAS) presents significant challenges regarding secondary prevention. A 48-year-old woman with pancreatic cancer experienced two episodes of large-vessel occlusion stroke was treated by mechanical thrombectomy. Subcutaneous heparin was discontinued owing to skin reactions, and recurrence occurred despite the use of a direct oral anticoagulant. As an alternative, intravenous heparin was initiated at home via a chemotherapy port, using a portable infusion pump. This individualized approach was implemented without any major complications, and it may represent a practical option for patients with CAS who are either intolerant or refractory to conventional therapies.
No takes yet. Share an insight, caveat, or question.
Kameda et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: